Discover TCR mimic antibodies that Target Previously “Undruggable” Intracellular Proteins with Keyway™ TCR
Webinar Overview: Unlock access to intracellular protein targets and maximize TCRm/TCR-based therapeutic antibody discovery with this presentation by Dr. Dongxing Zha that reveals how Alloy’s proprietary Keyway™ TCRm Discovery Platform and expertise can: Overcome challenges to intracellular protein-targeted drug discovery: Learn how the Keyway™ TCRm Discovery Platform identifies TCR mimic (TCRm) antibodies that target intracellular […]
Accelerating Bispecific Discovery with the Alloy Common Light Chain Platform
Webinar Overview Discover the full potential of bispecific antibody therapeutics and how to accelerate their discovery during this presentation by Dr. Lucy Liu that reveals how Alloy’s technologies, services, and expertise is able to: Accelerate bispecific antibody discovery: Learn how the Alloy Common Light Chain (CLC) human, transgenic platform streamlines bispecific antibody discovery and development, […]
Accelerating Therapeutic Discovery: ATX-Gx™ Human, Transgenic Platform
Webinar Overview Ready to dramatically accelerate your therapeutic antibody discovery pipeline? In this presentation, Dr. John “Lippy” Lippincott shares how our ATX-Gx™ human, transgenic mouse platform can help: Accelerate antibody discovery: Learn how this platform, used by 100’s of biotechs and large pharma, can significantly speed up the identification of therapeutic antibody candidates against diverse […]
High Velocity AI-Enabled and ML-Powered Therapeutic Antibody Discovery
High velocity, AI-enabled and ML-powered therapeutic antibody discovery and optimization Download the poster to see how Al/ML technologies and workflows combined with a proprietary high-throughput screening method accelerate antibody discovery and lead optimization. Download the poster Contact Us AI-enabled and ML-powered antibody discovery for faster and higher quality leads Therapeutic antibody discovery is becoming faster […]
Highly Specific anti-WT1/HLA-A2 TCRm Antibodies
New Data: unlocking the potential of TCRm antibodies Download the poster and explore the discovery of highly specific anti-WT1/HLA-A2 TCR-like antibodies. Download the poster Contact Us Keyway™ TCRm antibody discovery platform is revolutionizing immunotherapy development In a significant study, Alloy Therapeutics researchers identified T Cell Receptor mimic (TCRm) antibodies with exceptional specificity for the Wilms […]
How AI is reshaping antibody discovery and optimization workflows
In silico antibody discovery and optimization: How computational tools are reshaping the workflow AI-enabled and ML-powered methods are enabling faster identification and engineering of high-quality therapeutic antibody leads The field of antibody discovery is experiencing a transformative shift through the integration of cutting-edge artificial intelligence (AI) and machine learning (ML) technologies. Traditional methods of antibody […]
